212 related articles for article (PubMed ID: 7019711)
1. Oral flecainide acetate for the treatment of ventricular arrhythmias.
Anderson JL; Stewart JR; Perry BA; Van Hamersveld DD; Johnson TA; Conard GJ; Chang SF; Kvam DC; Pitt B
N Engl J Med; 1981 Aug; 305(9):473-7. PubMed ID: 7019711
[TBL] [Abstract][Full Text] [Related]
2. Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics.
Roden DM; Reele SB; Higgins SB; Mayol RF; Gammans RE; Oates JA; Woosley RL
N Engl J Med; 1980 Apr; 302(16):877-82. PubMed ID: 6767186
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
4. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study.
Anderson JL; Lutz JR; Nappi JM
Am J Cardiol; 1984 Feb; 53(4):522-7. PubMed ID: 6198894
[TBL] [Abstract][Full Text] [Related]
5. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
Bluschke V; Breithardt G; Abendroth RR; Seipel L
Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
[TBL] [Abstract][Full Text] [Related]
6. Oral flecainide for the treatment of drug-resistant ventricular ectopy.
Strasberg B; Stein S; Sclarovsky S
Isr J Med Sci; 1990 May; 26(5):258-61. PubMed ID: 1696248
[TBL] [Abstract][Full Text] [Related]
7. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
8. Oral flecainide for suppression of ventricular arrhythmias.
Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
[TBL] [Abstract][Full Text] [Related]
9. Relationship between plasma concentrations and suppression of ventricular extrasystoles by flecainide acetate (R-818), a new antiarrhythmic, in patients.
Conard GJ; Cronheim GE; Klempt HW
Arzneimittelforschung; 1982; 32(2):155-9. PubMed ID: 7199921
[TBL] [Abstract][Full Text] [Related]
10. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of flecainide acetate, a new antiarrhythmic agent, in humans.
Conard GJ; Carlson GL; Frost JW; Ober RE; Leon AS; Hunninghake DB
Clin Ther; 1984; 6(5):643-52. PubMed ID: 6478470
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of flecainide in patients with stable ventricular ectopic beats. Multicenter trial of the Italian Study Group on the Electrophysiology of Arrhythmias.
G Ital Cardiol; 1989 Apr; 19(4):360-70. PubMed ID: 2502464
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
Stroobandt R; Andries E; van Mieghem W; Kesteloot H
Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
[TBL] [Abstract][Full Text] [Related]
14. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
Klempt HW; Nayebagha A; Fabry E
Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
[TBL] [Abstract][Full Text] [Related]
15. [Study of flecainide in the treatment of ventricular arrhythmia].
Hug C; Koliopoulos N; Tardy C; Errera J; Puech P
Ann Cardiol Angeiol (Paris); 1983 May; 32(3):161-4. PubMed ID: 6193751
[TBL] [Abstract][Full Text] [Related]
16. Flecainide: a new agent for the treatment of ventricular arrhythmias.
Grubb BP; Tilley-Gray B
Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
[TBL] [Abstract][Full Text] [Related]
17. Flecainide dose-response relations in stable ventricular arrhythmias.
Woosley RL; Siddoway LA; Duff HJ; Roden DM
Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
[TBL] [Abstract][Full Text] [Related]
18. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
[TBL] [Abstract][Full Text] [Related]
19. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
[TBL] [Abstract][Full Text] [Related]
20. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
